D
Rhythm Pharmaceuticals, Inc. RYTM
$50.97 $0.731.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 41.83M 33.25M 29.08M 25.97M 24.23M
Total Other Revenue -- -- -- -- --
Total Revenue 41.83M 33.25M 29.08M 25.97M 24.23M
Cost of Revenue 3.79M 3.83M 2.95M 2.81M 3.23M
Gross Profit 38.04M 29.42M 26.13M 23.16M 21.00M
SG&A Expenses 38.13M 35.38M 36.42M 34.38M 32.37M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 83.09M 77.14M 69.56M 165.85M 65.50M
Operating Income -41.26M -43.89M -40.48M -139.89M -41.27M
Income Before Tax -43.38M -43.99M -31.78M -141.07M -41.44M
Income Tax Expenses -90.00K -344.00K 479.00K 300.00K 196.00K
Earnings from Continuing Operations -43.29M -43.64M -32.26M -141.37M -41.63M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -43.29M -43.64M -32.26M -141.37M -41.63M
EBIT -41.26M -43.89M -40.48M -139.89M -41.27M
EBITDA -40.87M -43.50M -40.09M -139.48M -40.85M
EPS Basic -0.72 -0.73 -0.55 -2.35 -0.70
Normalized Basic EPS -0.44 -0.45 -0.33 -1.47 -0.44
EPS Diluted -0.72 -0.73 -0.55 -2.35 -0.70
Normalized Diluted EPS -0.44 -0.45 -0.33 -1.47 -0.44
Average Basic Shares Outstanding 61.60M 61.22M 61.01M 60.14M 59.21M
Average Diluted Shares Outstanding 61.60M 61.22M 61.01M 60.14M 59.21M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings